Risk of lymphedema after regional nodal irradiation with breast conservation therapy.
Identifieur interne : 008E06 ( Main/Exploration ); précédent : 008E05; suivant : 008E07Risk of lymphedema after regional nodal irradiation with breast conservation therapy.
Auteurs : John J. Coen [États-Unis] ; Alphonse G. Taghian ; Lisa A. Kachnic ; Sherif I. Assaad ; Simon N. PowellSource :
- International journal of radiation oncology, biology, physics [ 0360-3016 ] ; 2003.
Descripteurs français
- KwdFr :
- Aisselle, Association thérapeutique, Boston (épidémiologie), Cyclophosphamide (administration et posologie), Doxorubicine (administration et posologie), Facteurs de risque, Femelle, Fluorouracil (administration et posologie), Fractionnement de la dose d'irradiation, Humains, Irradiation ganglionnaire (effets indésirables), Lymphadénectomie (effets indésirables), Lymphoedème (épidémiologie), Lymphoedème (étiologie), Mastectomie partielle (effets indésirables), Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique), Radiothérapie adjuvante (effets indésirables), Radiothérapie de haute énergie (effets indésirables), Résultat thérapeutique, Tables de survie, Tamoxifène (administration et posologie), Traitement médicamenteux adjuvant, Traitement néoadjuvant, Tumeurs du sein (), Tumeurs du sein (radiothérapie), Tumeurs du sein (traitement médicamenteux), Tumeurs primitives multiples (), Tumeurs primitives multiples (radiothérapie), Études rétrospectives.
- MESH :
- administration et posologie : Cyclophosphamide, Doxorubicine, Fluorouracil, Tamoxifène.
- effets indésirables : Irradiation ganglionnaire, Lymphadénectomie, Mastectomie partielle, Radiothérapie adjuvante, Radiothérapie de haute énergie.
- radiothérapie : Tumeurs du sein, Tumeurs primitives multiples.
- traitement médicamenteux : Tumeurs du sein.
- usage thérapeutique : Protocoles de polychimiothérapie antinéoplasique.
- épidémiologie : Boston, Lymphoedème.
- étiologie : Lymphoedème.
- Aisselle, Association thérapeutique, Facteurs de risque, Femelle, Fractionnement de la dose d'irradiation, Humains, Résultat thérapeutique, Tables de survie, Traitement médicamenteux adjuvant, Traitement néoadjuvant, Tumeurs du sein, Tumeurs primitives multiples, Études rétrospectives.
English descriptors
- KwdEn :
- Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Axilla, Boston (epidemiology), Breast Neoplasms (complications), Breast Neoplasms (drug therapy), Breast Neoplasms (radiotherapy), Breast Neoplasms (surgery), Chemotherapy, Adjuvant, Combined Modality Therapy, Cyclophosphamide (administration & dosage), Dose Fractionation, Doxorubicin (administration & dosage), Female, Fluorouracil (administration & dosage), Humans, Life Tables, Lymph Node Excision (adverse effects), Lymphatic Irradiation (adverse effects), Lymphedema (epidemiology), Lymphedema (etiology), Mastectomy, Segmental (adverse effects), Neoadjuvant Therapy, Neoplasms, Multiple Primary (complications), Neoplasms, Multiple Primary (radiotherapy), Neoplasms, Multiple Primary (surgery), Radiotherapy, Adjuvant (adverse effects), Radiotherapy, High-Energy (adverse effects), Retrospective Studies, Risk Factors, Tamoxifen (administration & dosage), Treatment Outcome.
- MESH :
- chemical , administration & dosage : Cyclophosphamide, Doxorubicin, Fluorouracil, Tamoxifen.
- geographic , epidemiology : Boston.
- adverse effects : Lymph Node Excision, Lymphatic Irradiation, Mastectomy, Segmental, Radiotherapy, Adjuvant, Radiotherapy, High-Energy.
- complications : Breast Neoplasms, Neoplasms, Multiple Primary.
- drug therapy : Breast Neoplasms.
- epidemiology : Lymphedema.
- etiology : Lymphedema.
- radiotherapy : Breast Neoplasms, Neoplasms, Multiple Primary.
- surgery : Breast Neoplasms, Neoplasms, Multiple Primary.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols.
- Axilla, Chemotherapy, Adjuvant, Combined Modality Therapy, Dose Fractionation, Female, Humans, Life Tables, Neoadjuvant Therapy, Retrospective Studies, Risk Factors, Treatment Outcome.
Abstract
To evaluate the risk factors for lymphedema in patients receiving breast conservation therapy for early-stage breast cancer.
PubMed: 12654429
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004308
- to stream PubMed, to step Curation: 004308
- to stream PubMed, to step Checkpoint: 004308
- to stream Ncbi, to step Merge: 000D01
- to stream Ncbi, to step Curation: 000D01
- to stream Ncbi, to step Checkpoint: 000D01
- to stream Main, to step Merge: 009081
- to stream Main, to step Curation: 008E06
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Risk of lymphedema after regional nodal irradiation with breast conservation therapy.</title>
<author><name sortKey="Coen, John J" sort="Coen, John J" uniqKey="Coen J" first="John J" last="Coen">John J. Coen</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. snpowell@partners.org</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114</wicri:regionArea>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Taghian, Alphonse G" sort="Taghian, Alphonse G" uniqKey="Taghian A" first="Alphonse G" last="Taghian">Alphonse G. Taghian</name>
</author>
<author><name sortKey="Kachnic, Lisa A" sort="Kachnic, Lisa A" uniqKey="Kachnic L" first="Lisa A" last="Kachnic">Lisa A. Kachnic</name>
</author>
<author><name sortKey="Assaad, Sherif I" sort="Assaad, Sherif I" uniqKey="Assaad S" first="Sherif I" last="Assaad">Sherif I. Assaad</name>
</author>
<author><name sortKey="Powell, Simon N" sort="Powell, Simon N" uniqKey="Powell S" first="Simon N" last="Powell">Simon N. Powell</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:12654429</idno>
<idno type="pmid">12654429</idno>
<idno type="wicri:Area/PubMed/Corpus">004308</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004308</idno>
<idno type="wicri:Area/PubMed/Curation">004308</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004308</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004308</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004308</idno>
<idno type="wicri:Area/Ncbi/Merge">000D01</idno>
<idno type="wicri:Area/Ncbi/Curation">000D01</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000D01</idno>
<idno type="wicri:doubleKey">0360-3016:2003:Coen J:risk:of:lymphedema</idno>
<idno type="wicri:Area/Main/Merge">009081</idno>
<idno type="wicri:Area/Main/Curation">008E06</idno>
<idno type="wicri:Area/Main/Exploration">008E06</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Risk of lymphedema after regional nodal irradiation with breast conservation therapy.</title>
<author><name sortKey="Coen, John J" sort="Coen, John J" uniqKey="Coen J" first="John J" last="Coen">John J. Coen</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. snpowell@partners.org</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114</wicri:regionArea>
<placeName><region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Taghian, Alphonse G" sort="Taghian, Alphonse G" uniqKey="Taghian A" first="Alphonse G" last="Taghian">Alphonse G. Taghian</name>
</author>
<author><name sortKey="Kachnic, Lisa A" sort="Kachnic, Lisa A" uniqKey="Kachnic L" first="Lisa A" last="Kachnic">Lisa A. Kachnic</name>
</author>
<author><name sortKey="Assaad, Sherif I" sort="Assaad, Sherif I" uniqKey="Assaad S" first="Sherif I" last="Assaad">Sherif I. Assaad</name>
</author>
<author><name sortKey="Powell, Simon N" sort="Powell, Simon N" uniqKey="Powell S" first="Simon N" last="Powell">Simon N. Powell</name>
</author>
</analytic>
<series><title level="j">International journal of radiation oncology, biology, physics</title>
<idno type="ISSN">0360-3016</idno>
<imprint><date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term>
<term>Axilla</term>
<term>Boston (epidemiology)</term>
<term>Breast Neoplasms (complications)</term>
<term>Breast Neoplasms (drug therapy)</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Chemotherapy, Adjuvant</term>
<term>Combined Modality Therapy</term>
<term>Cyclophosphamide (administration & dosage)</term>
<term>Dose Fractionation</term>
<term>Doxorubicin (administration & dosage)</term>
<term>Female</term>
<term>Fluorouracil (administration & dosage)</term>
<term>Humans</term>
<term>Life Tables</term>
<term>Lymph Node Excision (adverse effects)</term>
<term>Lymphatic Irradiation (adverse effects)</term>
<term>Lymphedema (epidemiology)</term>
<term>Lymphedema (etiology)</term>
<term>Mastectomy, Segmental (adverse effects)</term>
<term>Neoadjuvant Therapy</term>
<term>Neoplasms, Multiple Primary (complications)</term>
<term>Neoplasms, Multiple Primary (radiotherapy)</term>
<term>Neoplasms, Multiple Primary (surgery)</term>
<term>Radiotherapy, Adjuvant (adverse effects)</term>
<term>Radiotherapy, High-Energy (adverse effects)</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Tamoxifen (administration & dosage)</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Aisselle</term>
<term>Association thérapeutique</term>
<term>Boston (épidémiologie)</term>
<term>Cyclophosphamide (administration et posologie)</term>
<term>Doxorubicine (administration et posologie)</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Fluorouracil (administration et posologie)</term>
<term>Fractionnement de la dose d'irradiation</term>
<term>Humains</term>
<term>Irradiation ganglionnaire (effets indésirables)</term>
<term>Lymphadénectomie (effets indésirables)</term>
<term>Lymphoedème (épidémiologie)</term>
<term>Lymphoedème (étiologie)</term>
<term>Mastectomie partielle (effets indésirables)</term>
<term>Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique)</term>
<term>Radiothérapie adjuvante (effets indésirables)</term>
<term>Radiothérapie de haute énergie (effets indésirables)</term>
<term>Résultat thérapeutique</term>
<term>Tables de survie</term>
<term>Tamoxifène (administration et posologie)</term>
<term>Traitement médicamenteux adjuvant</term>
<term>Traitement néoadjuvant</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (radiothérapie)</term>
<term>Tumeurs du sein (traitement médicamenteux)</term>
<term>Tumeurs primitives multiples ()</term>
<term>Tumeurs primitives multiples (radiothérapie)</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cyclophosphamide</term>
<term>Doxorubicin</term>
<term>Fluorouracil</term>
<term>Tamoxifen</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Boston</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Cyclophosphamide</term>
<term>Doxorubicine</term>
<term>Fluorouracil</term>
<term>Tamoxifène</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term>
<term>Lymphatic Irradiation</term>
<term>Mastectomy, Segmental</term>
<term>Radiotherapy, Adjuvant</term>
<term>Radiotherapy, High-Energy</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term>
<term>Neoplasms, Multiple Primary</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Irradiation ganglionnaire</term>
<term>Lymphadénectomie</term>
<term>Mastectomie partielle</term>
<term>Radiothérapie adjuvante</term>
<term>Radiothérapie de haute énergie</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term>
<term>Neoplasms, Multiple Primary</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs du sein</term>
<term>Tumeurs primitives multiples</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
<term>Neoplasms, Multiple Primary</term>
</keywords>
<keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Protocoles de polychimiothérapie antinéoplasique</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Boston</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Axilla</term>
<term>Chemotherapy, Adjuvant</term>
<term>Combined Modality Therapy</term>
<term>Dose Fractionation</term>
<term>Female</term>
<term>Humans</term>
<term>Life Tables</term>
<term>Neoadjuvant Therapy</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Aisselle</term>
<term>Association thérapeutique</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Fractionnement de la dose d'irradiation</term>
<term>Humains</term>
<term>Résultat thérapeutique</term>
<term>Tables de survie</term>
<term>Traitement médicamenteux adjuvant</term>
<term>Traitement néoadjuvant</term>
<term>Tumeurs du sein</term>
<term>Tumeurs primitives multiples</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To evaluate the risk factors for lymphedema in patients receiving breast conservation therapy for early-stage breast cancer.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Massachusetts</li>
</region>
</list>
<tree><noCountry><name sortKey="Assaad, Sherif I" sort="Assaad, Sherif I" uniqKey="Assaad S" first="Sherif I" last="Assaad">Sherif I. Assaad</name>
<name sortKey="Kachnic, Lisa A" sort="Kachnic, Lisa A" uniqKey="Kachnic L" first="Lisa A" last="Kachnic">Lisa A. Kachnic</name>
<name sortKey="Powell, Simon N" sort="Powell, Simon N" uniqKey="Powell S" first="Simon N" last="Powell">Simon N. Powell</name>
<name sortKey="Taghian, Alphonse G" sort="Taghian, Alphonse G" uniqKey="Taghian A" first="Alphonse G" last="Taghian">Alphonse G. Taghian</name>
</noCountry>
<country name="États-Unis"><region name="Massachusetts"><name sortKey="Coen, John J" sort="Coen, John J" uniqKey="Coen J" first="John J" last="Coen">John J. Coen</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008E06 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 008E06 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:12654429 |texte= Risk of lymphedema after regional nodal irradiation with breast conservation therapy. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:12654429" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |